Letter to the editor: "Quantifying albumin permeability with multiphoton microscopy: why the difference?".

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Intravital Multiphoton Microscopy as a Tool for Studying Renal Physiology, Pathophysiology and Therapeutics.Frontiers in physiology · 2022
   Review
2. Mechanism of how carbamylation reduces albumin binding to FcRn contributing to increased vascular clearance.American journal of physiology. Renal physiology · 2021
   Article
3. Live-Animal Imaging of Renal Function by Multiphoton Microscopy.Current protocols in cytometry · 2018
   Article
4. Intravital multiphoton microscopy as a tool for studying renal physiology and pathophysiology.Methods (San Diego, Calif.) · 2017
   Review

Corrections and comments

• Commented on by
  Reply to "Letter to the editor: 'Quantifying albumin permeability with multiphoton microscopy: why the difference?'".2014
• Commented on by
  Reply to "Letter to the editor: 'Quantifying albumin permeability with multiphoton microscopy: why the difference?'".2014

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.